Last reviewed · How we verify

NCT06779578

Fluoroscopic-Guided Bipolar Versus Monopolar Pulsed Radiofrequency for Refractory Trigeminal Neuralgia

Recruiting now NA Last updated 17 January 2025
What this trial tests

NA trial testing Bipolar pulsed radiofrequency in Trigeminal Neuralgia in 20 participants. Currently enrolling.

Timeline
1 January 2024
Primary endpoint
1 June 2025
1 September 2025

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 January 2024
Primary completion1 June 2025
Estimated completion1 September 2025
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Eligibility, any sex, with Trigeminal Neuralgia or Refractory Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective exploratory study aiming at comparing pulsed bipolar versus pulsed unipolar radiofrequency ablation in patients with medically refractory trigeminal neuralgia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Trigeminal Neuralgia

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06779578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing